_×
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Recombinant Protein > Human Cell Expressed > IL2RG / CD132 Protein

IL2RG / CD132 Protein (Cytokine) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
10555-H02H
  YES          

Protein Production & Purification Service

Interleukin 2 receptor, gamma Protein Datasheet

 

IL2RG / CD132 Protein Price Inquiry ( Available Sizes )

IL2RG / CD132 Protein Product Information

Synonym : IL2RG
Protein Construction:

A DNA sequence encoding the human IL2RG(P31785) (Met1-Asn254 ) was expressed, fused with the Fc region of human IgG1 at the C-terminus.

Source: Human
Expression Host: Human Cells

IL2RG / CD132 Protein QC Testing

Purity: > 99 % as determined by SDS-PAGE SDS-PAGE:
SDS-PAGE

IL2RG / CD132 protein

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
Stability: Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal: Leu 23
Molecular Mass:

The recombinant human IL2RG/Fc is a disulfide-linked homodimer. The reduced monomer comprises 473 amino acids and has a predicted molecular mass of 54.4 kDa. The apparent molecular mass of the protein is approximately 71 kDa in SDS-PAGE under reducing conditions.

Formulation: Lyophilized from sterile PBS, pH7.4.
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
  2. Please contact us for any concerns or special requirements.

IL2RG / CD132 Protein Usage Guide

Storage: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

IL2RG / CD132 Protein Related Products & Topics

Related Areas:

Immunology>>Cytokine & Receptor>>Interleukin & Receptor>>Other>>CD132/IL2RG

Immunology>>Cluster of Differentiation>>T Cell CD Antigen>>Helper T Cells>>CD132/IL2RG

Proteins:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CD132/IL2RG Human IL2RG / CD132 Protein, Recombinant 10555-H02H
CD132/IL2RG Human IL2RG / CD132 Protein, Recombinant 10555-H08B
CD132/IL2RG Mouse CD132/IL2RG/Fc Protein, Recombinant 50087-M03H
CD132/IL2RG Mouse CD132/IL2RG Protein, Recombinant 50087-M08H
CD132/IL2RG Rat IL2RG / CD132 Protein, Recombinant 80197-R02H
CD132/IL2RG Rat IL2RG / CD132 Protein, Recombinant 80197-R08H

Antibodies:

Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Mouse CD132/IL2RG WB, ELISA CD132 / IL2RG Antibody 50087-RP01
Mouse CD132/IL2RG WB, ELISA CD132 / IL2RG Antibody (Antigen Affinity Purified) 50087-RP02

IL2RG / CD132 Protein Description

The interleukin 2 receptor (IL-2R) is a heterotrimeric protein expressed on the surface of certain immune cells, such as lymphocytes, which binds and responds to the cytokine IL-2. Three distinct chains of IL-2R, termed as α, β and γ, which are non-covalently associated are identified. The α and β chains are involved in binding IL-2, while signal transduction following cytokine interaction is carried out by the γ chain, along with the β subunit which are members of the type I cytokine receptor family. The α chain of the IL-2R can bind to the β chain before receptor interaction with IL-2. The γ chain alone has a very weak affinity for IL-2, but after the ligand is bound to the α/β heterodimer, the γ chain becomes recruited to the complex to form a very stable macromolecular quaternary ligand/receptor complex. It is proposed that the γ chain is common to the IL2, IL4, IL7, IL21 and probably also the IL13 receptors.

References

  1. Robb RJ. et al., 1981, J Exp Med. 154 (5): 1455-74.
  2. Leonard WJ. et al., 1982, Nature. 300 (5889): 267-9.
  3. Sharon M. et al., 1986, Science. 234 (4778): 859-63.
  4. Tsudo M. et al., 1987, Proc Natl Acad Sci.? 84 (12): 4215-8.
  5. Takeshita T. et al., 1992, J Immunol. 148 (7): 2154-8.
  6. Johnson K. et al., 1994, Eur Cytokine Netw. 5 (1): 23-34.